Loading market dashboard
Eldridge BBB-B CLO ETF
CLOZFinancial ServicesAMEXUS
Loading disclosure news
News and disclosures filtered by period, publisher, and event group.
Select a headline to open the full news page in the app.
Collateralized loan obligations (CLOs) are securitized portfolios of corporate loans divided into tranches by risk profile. For many retail investors, CLOs can be foreign and uncomfortable, but the potential for attractive yields, floating-rate income, and diversification is strong.
Federal Reserve hikes are increasingly likely, with inflation increasing and unemployment stable. Lots of investments and ETFs should outperform during a period of rising rates. I'll be giving a quick rundown of four such ETFs in this article. Funds vary in risk, from cash ETFs to riskier choices, with the possibility of outstanding gains.
With Fed rates stabilizing, and the market turning hawkish, variable rate investments deserve another look. The Eldridge BBB-B CLO ETF (CLOZ) focuses on variable rate BBB-BB CLOs. It sports an above-average 7.0% dividend yield, and has outperformed most bonds on an absolute and risk-adjusted basis.
Farther Finance Advisors LLC lifted its position in shares of Eldridge BBB-B CLO ETF (NYSEARCA:CLOZ) by 271.0% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 37,842 shares of the company's stock after buying an additional 27,641
Eldridge BBB-B CLO ETF (NYSEARCA:CLOZ - Get Free Report) was the recipient of a large growth in short interest in February. As of February 27th, there was short interest totaling 4,536,418 shares, a growth of 14.5% from the February 12th total of 3,961,683 shares. Approximately 15.8% of the shares of the company are sold short.
Eldridge BBB-B CLO ETF offers an 8% yield, but recent price declines reflect tighter credit spreads and market volatility. CLOZ's income relies on elevated interest rates; falling rates in 2026 could pressure distributions and necessitate payout cuts. The portfolio is diversified, with 62.6% in CLO BBB tranches and significant exposure to high-tech, banking, and healthcare sectors.
